Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper
ChemImage has released a white paper discussing improvements in the development of imaging technology used to visualize anatomic structures for both normal and diseased tissue that minimizes the learning curve, provides real-time information, simplifies surgical procedures, lowers surgical costs and potentially enhances patient outcomes during robot-assisted surgical procedures.
The clinical and scientific teams at ChemImage have demonstrated, in investigational studies performed under Institutional Review Board approvals, effective discrimination of a variety of anatomic structures such as bladder, uterus, colon, ureter, vasculature, prostate and kidney, as well as cancer tumor margins within bladders, prostates and kidneys.
The white paper, entitled "Innovative Molecular Chemical Imaging Technology to Improve Outcomes for Robot-Assisted Surgical Procedures", provides a summary of initial work which has been completed by the scientific team at ChemImage.
About ChemImage Corporation
ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.
ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics.
For more information, contact ChemImage.